Tenax Therapeutics, Inc. (TENX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 478.06M |
| Enterprise Value | 380.49M |
| P/E Ratio | -12.45 |
| PEG Ratio | 4.16 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 6.92 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -3.16 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.47 |
| Return On Equity | -0.56 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -52.6M |
| Net Income | -52.6M |
| Diluted EPS | -1.34 |
| Total Cash | 118.76M |
| Total Cash/Share | 2.63 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 14.52 |
| Book Value Per Share | 2.54 |
| 52-Week Change | 197.46 |
| 52-Week High | 19.4 |
| 52-Week Low | 5.77 |
| Moving Average 50 Days | 12.64 |
| Moving Average 200 Days | 11.66 |
| Average Volume | 932,601 |
| Shares Outstanding | 17.2M |
| % Held by Institutions | 54.12 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:80 |
| Last Split Date | January 03, 2024 |